Bitcoin Breaks $100,000 Barrier Again Amid U.S.-UK Trade Deal Optimism

/in /tarafından

Bitcoin surged past the $100,000 mark on Thursday, regaining ground for the first time since February and reflecting renewed investor confidence following a breakthrough trade deal between the United States and the United Kingdom.

By midday, Bitcoin was trading at $101,329.97, up 4.7% on the day, buoyed by improved global risk sentiment. The crypto asset has now entered positive territory for 2025, although it still trails its January all-time high of over $109,000.

The rally follows the announcement of a U.S.-UK trade agreement between President Donald Trump and British Prime Minister Keir Starmer. The deal maintains a 10% U.S. tariff on UK imports but includes Britain lowering its tariffs to 1.8% and expanding access to U.S. goods — signaling a potential thaw in the protectionist climate that has defined global trade since Trump’s return to office.

Market Impact and Commentary:

  • Antoni Trenchev, co-founder of Nexo, described the resurgence as a “formidable feat” and emphasized that long-term holders drove the rebound, overpowering short-term profit-taking.

  • “Buying peak fear — just last month Bitcoin was languishing around $74,000 — has proven exceptionally lucrative,” Trenchev added.

  • Joel Kruger of LMAX Group pointed to rising institutional interest, geopolitical stability, and Chinese monetary stimulus as key tailwinds behind the rally.

Other Cryptos Lag Behind:
Ethereum’s native token Ether climbed 14% to $2,050.46, reaching a one-month high, but it remains nearly 50% below its 2024 peak. Other altcoins have yet to mirror Bitcoin’s bullish momentum.

Bitcoin’s trajectory was weighed down earlier this year by uncertainty around the pace of pro-crypto reform under Trump’s new administration. April’s widespread tariff announcements spurred a flight to safety, leading to a temporary slump in risk assets, including crypto.

Now, with geopolitical risk easing and renewed appetite from long-term investors and institutional funds — particularly through Bitcoin ETFs — market sentiment appears to have decisively shifted back in favor of crypto’s largest token.

With the $100,000 psychological level reclaimed, traders are eyeing $109,000 and beyond as the next major milestone.

Warner Bros Discovery Eyes Potential Breakup Amid Revenue Miss and Cable Decline

/in /tarafından

Warner Bros Discovery (WBD) is reportedly moving toward a potential company breakup, according to CNBC, as it looks to shed its struggling cable TV division and concentrate on faster-growing streaming and studio segments. The news sent WBD shares climbing over 4%, partially offsetting a sharp 6% drop earlier in the day following disappointing Q1 earnings.

The strategic shift comes as the broader media industry undergoes a profound transformation. Cord-cutting continues to erode the profitability of traditional cable networks, pushing media giants like WBD to reevaluate their core assets. WBD, which was formed through the 2022 merger of Warner Media and Discovery, had already taken initial steps in December by operationally separating its cable TV division from its studio and streaming units.

KEY FINANCIAL HIGHLIGHTS:

  • Revenue: Fell 10% YoY to $8.98 billion, missing analyst expectations of $9.60 billion.

  • Earnings: Posted a wider-than-expected loss of $0.18 per share versus the forecasted $0.13 loss.

  • Studio revenue: Dropped 18% to $2.31 billion, missing the $2.73 billion consensus.

  • Cable networks revenue: Declined 7%.

  • Streaming performance: A bright spot, with Max adding 5.3 million subscribers, beating estimates and bringing its total base to 122.3 million.

CEO David Zaslav highlighted Max’s continued appeal in the competitive streaming space, driven by strong programming like The White Lotus and The Pitt. Still, the studio division underperformed due to weak box office results — most notably the underwhelming performance of Mickey 17, which failed to replicate the success of Dune: Part Two.

On a more optimistic note, Q2 appears to be off to a better start. WBD’s latest theatrical releases — Ryan Coogler’s Sinners and A Minecraft Movie — have garnered major success, with the latter earning nearly $900 million globally and becoming 2025’s biggest box office hit to date.

A potential split would align WBD with peers like Comcast, which is also spinning off traditional cable properties in favor of a more streamlined digital content model. However, analysts caution that divesting cable assets could be challenging due to WBD’s heavy debt burden of $38 billion and the declining appeal of linear TV.

“WBD would be leaner and have stronger growth potential without cable assets,” noted eMarketer’s Ross Benes. “But finding a buyer could be difficult.”

While Warner Bros Discovery has yet to comment on the breakup report, the path toward separation could reshape its future trajectory as it competes for relevance and revenue in an increasingly digital-first entertainment industry.

U.S. FDA to Roll Out AI Tools Across All Centers Following Successful Pilot

/in /tarafından

The U.S. Food and Drug Administration (FDA) announced it will immediately begin deploying artificial intelligence tools internally across all of its centers, with full integration expected by June 30. The move follows a successful generative AI pilot aimed at supporting scientific reviewers in accelerating the drug review process.

WHY IT MATTERS:
The FDA typically has 6 to 10 months to evaluate a drug approval application. The newly tested generative AI tools are designed to ease the burden on scientists by automating repetitive and time-consuming tasks, thereby streamlining the overall review process and potentially speeding up access to life-saving treatments.

In a statement, the agency emphasized that the focus of future AI enhancements would be on usability, better document integration, and center-specific output customization — all while upholding strict data security and FDA compliance standards.

KEY QUOTE:
“Future enhancements will focus on improving usability, expanding document integration and tailoring outputs to center-specific needs, while maintaining strict information security and compliance with FDA policy,” the FDA said.

CONTEXT:
The announcement comes just a day after Wired reported that the FDA had been in discussions with OpenAI, the maker of ChatGPT, regarding potential AI collaborations. The report also mentioned that representatives from Elon Musk’s Department of Government Efficiency had attended multiple meetings with both the FDA and OpenAI in recent weeks.

WHAT’S NEXT:
The FDA plans to monitor the system’s performance closely, solicit feedback from its users, and refine the tools accordingly. The agency has committed to releasing more information about the AI implementation and its outcomes in June.

This marks one of the most significant government-level adoptions of generative AI to date and could signal a broader shift toward AI-assisted regulatory workflows in the healthcare and pharmaceutical sectors.